Martingale Asset Management’s Emergent Biosolutions EBS Stock Holding History

Martingale Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-62,300	Closed	-$425K	–	802
2024 Q2	$425K	Buy	+62,300	New	+$425K	0.01%	633
2023 Q4	–	Sell	-79,833	Closed	-$271K	–	804
2023 Q3	$271K	Buy	79,833 +31,721	+66%	+$108K	0.01%	703
2023 Q2	$354K	Sell	48,112 -4,500	-9%	-$33.1K	0.01%	675
2023 Q1	$545K	Buy	52,612 +11,508	+28%	+$119K	0.01%	597
2022 Q4	$485K	Buy	41,104 +13,118	+47%	+$155K	0.01%	620
2022 Q3	$588K	Buy	27,986 +6,397	+30%	+$134K	0.01%	582
2022 Q2	$671K	Hold	21,589	–	–	0.01%	579
2022 Q1	$887K	Sell	21,589 -500	-2%	-$20.5K	0.01%	518
2021 Q4	$961K	Buy	22,089 +1,703	+8%	+$74.1K	0.01%	505
2021 Q3	$1.02M	Buy	20,386 +8,071	+66%	+$404K	0.01%	501
2021 Q2	$776K	Buy	+12,315	New	+$776K	0.01%	478
2018 Q3	–	Sell	-7,406	Closed	-$374K	–	967
2018 Q2	$374K	Sell	7,406 -13,205	-64%	-$667K	﹤0.01%	903
2018 Q1	$1.09M	Hold	20,611	–	–	0.01%	712
2017 Q4	$958K	Buy	20,611 +2,205	+12%	+$102K	0.01%	710
2017 Q3	$745K	Buy	18,406 +5,100	+38%	+$206K	0.01%	784
2017 Q2	$452K	Buy	+13,306	New	+$452K	0.01%	837
2016 Q2	–	Sell	-10,288	Closed	-$374K	–	839
2016 Q1	$374K	Sell	10,288 -1	-0%	-$36	0.01%	702
2015 Q4	$412K	Sell	10,289 -4,501	-30%	-$180K	0.01%	692
2015 Q3	$422K	Sell	14,790 -9,322	-39%	-$266K	0.01%	676
2015 Q2	$795K	Sell	24,112 -6,102	-20%	-$201K	0.02%	578
2015 Q1	$869K	Sell	30,214 -1,300	-4%	-$37.4K	0.02%	574
2014 Q4	$859K	Sell	31,514 -3,800	-11%	-$104K	0.02%	572
2014 Q3	$753K	Hold	35,314	–	–	0.02%	588
2014 Q2	$794K	Sell	35,314 -500	-1%	-$11.2K	0.02%	584
2014 Q1	$906K	Sell	35,814 -1,000	-3%	-$25.3K	0.03%	528
2013 Q4	$847K	Sell	36,814 -25,612	-41%	-$589K	0.03%	606
2013 Q3	$1.19M	Buy	62,426 +1	+0%	+$19	0.04%	439
2013 Q2	$901K	Buy	+62,425	New	+$901K	0.03%	536